The Alouette Test in Parkinson Disease

Screening for Reading Difficulties in Parkinson's Disease: An Evaluation of the Alouette Test

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03958175

Acronym

REPEAT

Enrollment

Registered

2019-05-21

Start date

2015-11-01

Completion date

2016-04-01

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

Reading disorders in Parkinson's Disease (PD) are poorly evaluated due to the lack of validated tests to screen for them. They are often attributed to hand tremors associated with the disease. In this study, the investigating team evaluated the alouette test validated for dyslexia screening, in PD by comparing the results to healthy patients.

Interventions

OTHERAlouette test (reading test)

The alouette test was assessed at a fixed distance of 40 centimeters on a fixed surface to avoid errors related to hand tremors.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with Parkinson's Disease * Montreal Cognitive Assessment (MoCA) test \> 20

Exclusion criteria

* Patient's with supranuclear Palsy * Other neurologic disease * Any ophthalmologic disease * Presence of a nystagmus * Visual acuity \< 0.6

Design outcomes

Primary

Measure	Time frame	Description
Score on the Alouette test	1 day	The Alouette test is based on the precision and speed in reading a short text (279 words). The score corresponds to the total number of words correctly read.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026